Neuphoria Therapeutics Inc.

NEUP·NASDAQ·$5.46Share Price as of 11/2·$30MMarket Cap as of 11/2

Financials

10-KFY 202609/18/26 10-QQ3 ended 03/31/2605/15/26 10-QQ2 ended 12/31/2502/17/26 10-QQ1 ended 09/30/2511/14/25 10-KFY 202509/29/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report07/24/26 8-KCurrent report05/26/26 8-KCurrent report01/08/26 8-KCurrent report12/18/25

Prospectuses and Registrations

424B5Prospectus supplement11/14/25 424B5Prospectus supplement10/27/25 424B5Prospectus supplement10/20/25 424B5Prospectus supplement09/23/25 424B5Prospectus supplement07/29/25

Proxies

DEF 14ADefinitive proxy09/18/26 DEFA14AAdditional proxy materials09/18/26 DEFA14AAdditional proxy materials09/18/26 DEFA14AAdditional proxy materials07/24/26 DEFA14AAdditional proxy materials12/08/25

Ownership

SC 13GBeneficial ownership10/05/26 SC 13G/ABeneficial ownership (amended)07/28/26 SC 13G/ABeneficial ownership (amended)02/06/26 Form 4Insider transaction01/21/26 Form 4Insider transaction01/21/26

Other

NT 10-QLate filing notification (10-Q)05/15/25 EFFECTRequest for effectiveness01/29/25 CORRESPCorrespondence with the SEC01/28/25 UPLOADLetter from the SEC01/28/25 EFFECTRequest for effectiveness01/08/25